Two siRNAs, delivered by lipid nanoparticles, target vascular endothelial growth factor-a (VEGFa) and kinesin spindle protein (KSP) to reduce tumor microvascular density and to induce tumor cell mitotic arrest, respectively 270. This evidence concerns the gene VEGFA and neoplasm.